Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.
Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:
| (12) Patent Application: | (11) CA 2322549 |
|---|---|
| (54) English Title: | MEDICINAL PRODUCTS CREATED FROM CANNABIS USING CANNABINOID PROFILES AS INDICATORS OF EFFICACY |
| (54) French Title: | PRODUITS MEDICAUX OBTENUS A PARTIR DU CHANVRE EN UTILISANT DES PROFILES DE CANNABINOIDES COMME INDICATEURS D'EFFICACITE |
| Status: | Dead |
| (51) International Patent Classification (IPC): |
|
|---|---|
| (72) Inventors : |
|
| (73) Owners : |
|
| (71) Applicants : |
|
| (74) Agent: | NA |
| (74) Associate agent: | NA |
| (45) Issued: | |
| (22) Filed Date: | 2000-09-27 |
| (41) Open to Public Inspection: | 2002-03-27 |
| Availability of licence: | N/A |
| (25) Language of filing: | English |
| Patent Cooperation Treaty (PCT): | No |
|---|
| (30) Application Priority Data: | None |
|---|
A process is described whereby a back-crossing protocol is used to create
cannabis plants
which are further standardized into medicinal products. A specific lighting
regime is first
used to bring a cloned plant to the vegetative stage followed by treatment
with defined
type of Gibberellic Acid (GA3) which stimulates sex reversal; from a female to
a male.
The pollen from this new male is used to pollenate the mother plant with her
own pollen.
This procedure creates a new variety of true breeding plant with a
reproducible genome,
which can be cloned into more plants. Confirmation of reproducibility is
achieved us Gas
Chromatography/ Mass Spectroscopy (GC/MS) to determine the Cannabinoid Profile
of
the pollenated plant. This cannabinoid profile is used as an index for the
type of
medicinal product which can be produced. Once this profile is established the
raw
material is gound into a powder, the cannabinoid profile is re-verified and
the powder can
be used as a medicine for symptom relief from many different ailments such as
epileptic
siezures, glaucoma, nausea/pain, multiple sclerosis tremors, migraine,
fibromyalgia,
hepatitis, depression, anorexia, anxiety. Route of administration of this
powder can be
made either oral or by smoking.
Note: Claims are shown in the official language in which they were submitted.
Sorry, the claims for patent document number 2322549 were not found.
Text is not available for all patent documents. The current dates of coverage are on the
Currency of Information
page
Note: Descriptions are shown in the official language in which they were submitted.
Sorry, the representative drawing for patent document number 2322549 was not found.
For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Administrative Status , Maintenance Fee and Payment History should be consulted.
| Title | Date |
|---|---|
| Forecasted Issue Date | Unavailable |
| (22) Filed | 2000-09-27 |
| (41) Open to Public Inspection | 2002-03-27 |
| Dead Application | 2003-05-12 |
| Abandonment Date | Reason | Reinstatement Date |
|---|---|---|
| 2002-05-13 | FAILURE TO COMPLETE | |
| 2002-09-27 | FAILURE TO PAY APPLICATION MAINTENANCE FEE |
| Fee Type | Anniversary Year | Due Date | Amount Paid | Paid Date |
|---|---|---|---|---|
| Application Fee | $150.00 | 2000-09-27 |
Note: Records showing the ownership history in alphabetical order.
| Current Owners on Record |
|---|
| HORNBY, A. PAUL |
| SUTHERLAND, MARTIN D. |
| DIMOTOFF, PAVEL U. |
| Past Owners on Record |
|---|
| None |
